EU backs Novavax shot as region’s fifth Covid-19 vaccine

The European Union on Monday approved the use of Novavax’s Covid-19 vaccine in people 18 years and older, giving a boost to the US biotech after long delays and paving the way for a fifth shot in the EU as the Omicron variant spreads.